Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

Bibliographic Details
Main Authors: Bukan, N. (Author), Sancak, B. (Author), Coskun, U. (Author), Günel, N. (Author), Yucel, A. (Author), Ozenirler, S. (Author), Unal, A. (Author)
Format: Article
Language:Slovak
English
PhysicalDescription:Graf, tab.
ISSN:0028-2685
Subjects:
Description
Physical Description:Graf, tab.
ISSN:0028-2685
Bibliography:Res. angl.
Bibliogr. odkazy